Revvity (RVTY) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Revvity · Health Care · ref. ETF XLV · 50 calls · price $155.08
What the company does: Revvity, Inc. provides health sciences solutions, technologies, and services.
📈 Revvity (RVTY) stock price
$155.08+70.2% over range
Oct 14, 25low $82.26 · high $157.36Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
56% recommend buying · 9 analysts
📊 JPI status : Revvity has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 RVTY price target & analyst consensus — price $155
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$165+6.4%
Median target · of 8 targets$126-18.8%
Lowest target · 1 firm of 8$90-42.0%
Current price$155.08
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
338%
$160 ↔ $175
Below
563%
$90 ↔ $135
⏳ Targets haven't kept up with the price. 56% of ratings say “Buy”, yet 5 of 8 targets sit below the current price: the stock has risen past what analysts were aiming for, and some haven't raised their target yet. Read it as a dated view, not as a forecast of a drop.
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Barclays — 60% of its targets hit on this sector (645 calls tested). It aims for $160 (+3.2 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).
The 2 reliable analysts
$143-7.8 %
The 6 other firms
$130-16 %
How to read it: the 2 reliable firms are not filtered by optimism — 1 aim above the price, 1 below, hence their $143 median. “The 6 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 9 ratings (last 6 months)
Strong Buy00%
Buy556%
Hold444%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 RVTY price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on RVTY most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in RVTY? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Revvity? The JPI assistant answers using our backtest data.
💰 Revvity dividend: yield, history & growth › open the full page
0.25%annual yield
That's ~$0.28 per share per year.
📈 Revvity fundamentals: valuation, margins & growth › open the full page
P/E 74.6Net margin 8.2 %Revenue growth +1.3 %Very high P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 13 %
2023
Rev −40%Profit +20%
2024
Rev +0%Profit −61%
2025
Rev +4%Profit −11%
🔎 Detailed analyses
🏛️ Which US Congress members hold Revvity (RVTY)?
3 Congress members have disclosed RVTY buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
✅ Historical analyst reliability on RVTY
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Evercore ISI Group ↗ | 100% | +26.6% | 3 |
| B of A Securities ↗ | 67% | +21.8% | 3 |
| Keybanc ↗ | 67% | +15.2% | 3 |
| Goldman Sachs ↗ | 50% | +18.2% | 2 |
| Bernstein ↗ | 50% | -7.0% | 2 |
| Raymond James ↗ | 44% | +3.5% | 9 |
| Barclays ↗ | 20% | +2.5% | 5 |
| Baird ↗ | 20% | -8.8% | 5 |
| Leerink Partners ↗ | 0% | -12.1% | 2 |
| TD Cowen ↗ | 0% | -22.6% | 3 |
📊 What $1,000 invested in Revvity would be worth › open the full page
In short — $1,000 invested in Revvity 10 years ago would be worth $2,303 today, i.e. +9%/yr on average. Best year: 2020 (+59%), worst: 2023 (-22%). Price performance, excluding dividends.
If I'd invested $1,000 in Revvity
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $882 | -12% |
| 3 years ago | $809 | -19% |
| 5 years ago | $757 | -24% |
Return by year (Revvity)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +2% | $1,023 (+2%) |
| 2025 | -14% | $882 (-12%) |
| 2024 | +18% | $1,038 (+4%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Revvity
Loading news…
📋 All analyst calls on RVTY
Filtered on — · ✕ show all
▲ Buy · 🎯$175
Today : $155.08 — upside +13%
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
■ Equal-Weight neutral · not a buy · 🎯$160
Price at call : $152.16 — gap to target +5%
Today : $155.08 — gap to target +3%
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
William Blair ↗
Oct 6, 26
▲ Outperform
🎯 on RVTY : no call matured yet · 📊 on Health : 64.3% · +7.1% (28 calls)
in progress (365j)
matures : Oct 6, 27
matures : Oct 6, 27
▲ Overweight · 🎯$165
Price at call : $130.22 — upside +27%
Today : $155.08 — upside +6%
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 43.4% · -1.8% (145 calls)
in progress (365j)
matures : Sep 4, 27
matures : Sep 4, 27
RBC Capital ↗
Sep 1, 26
■ Sector Perform neutral · not a buy · 🎯$135
Price at call : $126.59 — gap to target +7%
Today : $155.08 — gap to target -13%
🎯 on RVTY : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Sep 1, 27
matures : Sep 1, 27
Evercore ISI Group ↗
Aug 5, 26
▲ Outperform · 🎯$126
Price at call : $114.24 — upside +10%
Today : $155.08 — upside -19%
🎯 on RVTY : 100% (2 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$125
Price at call : $112.05 — upside +12%
Today : $155.08 — upside -19%
🎯 on RVTY : 100% (2 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
■ Equal-Weight neutral · not a buy · 🎯$105
Price at call : $101 — gap to target +4%
Today : $155.08 — gap to target -32%
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
See the other 42 calls, newest to oldest
■ Neutral neutral · not a buy · 🎯$90
Price at call : $98.85 — gap to target -9%
Today : $155.08 — gap to target -42%
🎯 on RVTY : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Buy · 🎯$120
Price at call : $98.85 — upside +21%
Today : $155.08 — upside -23%
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
■ Hold neutral · not a buy · 🎯$100
Price at call : $98.85 — gap to target +1%
Today : $155.08 — gap to target -36%
🎯 on RVTY : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Outperform · 🎯$125
Price at call : $86.51 — upside +44%
Today : $155.08 — upside -19%
🎯 on RVTY : 50% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Goldman Sachs ↗
Apr 14, 26
■ Neutral neutral · not a buy · 🎯$95
Price at call : $92.9 — gap to target +2%
Today : $155.08 — gap to target -39%
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
■ Equal-Weight neutral · not a buy · 🎯$95
Price at call : $93.51 — gap to target +2%
Today : $155.08 — gap to target -39%
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
■ Neutral neutral · not a buy · 🎯$96
Price at call : $87.92 — gap to target +9%
Today : $155.08 — gap to target -38%
🎯 on RVTY : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Mar 31, 27
matures : Mar 31, 27
■ Neutral neutral · not a buy · 🎯$105
Price at call : $103.83 — gap to target +1%
Today : $155.08 — gap to target -32%
🎯 on RVTY : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
▲ Buy · 🎯$124
Price at call : $103.83 — upside +19%
Today : $155.08 — upside -20%
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
Evercore ISI Group ↗
Feb 3, 26
▲ Outperform · 🎯$118
Price at call : $101.13 — upside +17%
Today : $155.08 — upside -24%
🎯 on RVTY : 100% (2 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
Wells Fargo ↗
Feb 3, 26
■ Equal-Weight neutral · not a buy · 🎯$110
Price at call : $101.13 — gap to target +9%
Today : $155.08 — gap to target -29%
🎯 on RVTY : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
▲ Overweight · 🎯$118
Price at call : $101.13 — upside +17%
Today : $155.08 — upside -24%
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
■ Hold neutral · not a buy · 🎯$105
Price at call : $101.13 — gap to target +4%
Today : $155.08 — gap to target -32%
🎯 on RVTY : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
▲ Overweight · 🎯$115
Price at call : $96.27 — upside +19%
Today : $155.08 — upside -26%
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Wells Fargo ↗
Dec 15, 25
■ Equal-Weight neutral · not a buy · 🎯$107
Price at call : $96.27 — gap to target +11%
Today : $155.08 — gap to target -31%
🎯 on RVTY : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Goldman Sachs ↗
Dec 9, 25
■ Neutral neutral · not a buy · 🎯$105
Price at call : $98.78 — gap to target +6%
Today : $155.08 — gap to target -32%
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
▲ Overweight · 🎯$105
Price at call : $96.45 — upside +9%
Today : $155.08 — upside -32%
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
▲ Outperform · 🎯$123
Price at call : $96.45 — upside +28%
Today : $155.08 — upside -21%
🎯 on RVTY : 50% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Oct 28, 26
matures : Oct 28, 26
Guggenheim ↗
Oct 16, 25
■ Neutral neutral · not a buy
🎯 on RVTY : no call matured yet · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Oct 16, 26
matures : Oct 16, 26
Evercore ISI Group ↗
Oct 7, 25
▲ Outperform · 🎯$106
Price at call : $91.77 — upside +16%
Today : $155.08 — upside -32%
Expected +16% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on RVTY : 100% (2 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+65.8%
stock +66% · XLV +16%
matured Oct 7, 26
▲ Overweight · 🎯$100
Price at call : $91.46 — upside +9%
Today : $155.08 — upside -36%
Expected +9% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+65.7%
stock +66% · XLV +16%
matured Oct 2, 26
B of A Securities ↗
Sep 22, 25
▲ Buy · 🎯$99
Price at call : $85.71 — upside +16%
Today : $155.08 — upside -36%
Expected +16% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on RVTY : 67% (3 calls matureds) · 📊 on Health : 48.1% · +2.0% (362 calls)
+65.8%
stock +66% · XLV +23%
matured Sep 22, 26
Raymond James ↗
Jul 29, 25
▲ Outperform · 🎯$115
Price at call : $90.85 — upside +27%
Today : $155.08 — upside -26%
Expected +27% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
+25.0%
stock +25% · XLV +22%
matured Jul 29, 26
■ Hold neutral · not a buy · 🎯$110
Price at call : $94.47 — gap to target +16%
Today : $155.08 — gap to target -29%
🎯 on RVTY : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jul 29, 26
matures : Jul 29, 26
Evercore ISI Group ↗
Jul 8, 25
▲ Outperform · 🎯$115
Price at call : $100.66 — upside +14%
Today : $155.08 — upside -26%
Expected +14% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 100% (2 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+8.6%
stock +9% · XLV +20%
matured Jul 8, 26
B of A Securities ↗
Jun 26, 25
▲ Buy · 🎯$110
Price at call : $97.82 — upside +12%
Today : $155.08 — upside -29%
Expected +12% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 67% (3 calls matureds) · 📊 on Health : 48.1% · +2.0% (362 calls)
+13.7%
stock +14% · XLV +20%
matured Jun 26, 26
▲ Buy · 🎯$115
Price at call : $92.9 — upside +24%
Today : $155.08 — upside -26%
Expected +24% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 51.7% · +3.1% (358 calls)
-6.7%
stock -7% · XLV +6%
matured May 1, 26
Goldman Sachs ↗
Apr 29, 25
▲ Buy · 🎯$125
Price at call : $93.43 — upside +34%
Today : $155.08 — upside -19%
Expected +34% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 51.4% · +2.3% (243 calls)
-7.3%
stock -7% · XLV +4%
matured Apr 29, 26
■ Neutral neutral · not a buy · 🎯$100
Price at call : $93.43 — gap to target +7%
Today : $155.08 — gap to target -36%
🎯 on RVTY : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Apr 29, 26
matures : Apr 29, 26
Raymond James ↗
Apr 29, 25
▲ Outperform · 🎯$120
Price at call : $93.43 — upside +28%
Today : $155.08 — upside -23%
Expected +28% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-7.3%
stock -7% · XLV +4%
matured Apr 29, 26
▲ Outperform · 🎯$125
Price at call : $94.66 — upside +32%
Today : $155.08 — upside -19%
Expected +32% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 50% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-13.1%
stock -13% · XLV +3%
matured Apr 29, 26
▲ Outperform · 🎯$127
Price at call : $89.77 — upside +41%
Today : $155.08 — upside -18%
Expected +41% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 50% (2 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+5.0%
stock +5% · XLV +10%
matured Apr 21, 26
Wells Fargo ↗
Apr 17, 25
■ Equal-Weight neutral · not a buy · 🎯$102
Price at call : $89.77 — gap to target +14%
Today : $155.08 — gap to target -34%
🎯 on RVTY : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Apr 17, 26
matures : Apr 17, 26
▲ Overweight · 🎯$110
Price at call : $94.86 — upside +16%
Today : $155.08 — upside -29%
Expected +16% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-2.3%
stock -2% · XLV +8%
matured Apr 10, 26
▲ Overweight · 🎯$140
Price at call : $123.16 — upside +14%
Today : $155.08 — upside -10%
Expected +14% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-15.7%
stock -16% · XLV +6%
matured Feb 3, 26
Raymond James ↗
Feb 3, 25
▲ Outperform · 🎯$145
Price at call : $123.69 — upside +17%
Today : $155.08 — upside -6%
Expected +17% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-18.2%
stock -18% · XLV +5%
matured Feb 3, 26
▲ Overweight · 🎯$145
Price at call : $123.69 — upside +17%
Today : $155.08 — upside -6%
Expected +17% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 43.4% · -1.8% (145 calls)
-18.2%
stock -18% · XLV +5%
matured Feb 3, 26
Raymond James ↗
Jan 21, 25
▲ Outperform · 🎯$140
Price at call : $122.78 — upside +14%
Today : $155.08 — upside -10%
Expected +14% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 46.4% · +1.6% (403 calls)
-4.1%
stock -4% · XLV +11%
matured Jan 21, 26
B of A Securities ↗
Dec 13, 24
▲ Buy · 🎯$138
Price at call : $115.17 — upside +20%
Today : $155.08 — upside -11%
Expected +20% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 67% (3 calls matureds) · 📊 on Health : 48.1% · +2.0% (362 calls)
-14.0%
stock -14% · XLV +12%
matured Dec 13, 25
▲ Overweight · 🎯$135
Price at call : $115.07 — upside +17%
Today : $155.08 — upside -13%
Expected +17% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 25% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-9.0%
stock -9% · XLV +8%
matured Nov 25, 25
▲ Buy · 🎯$144
Price at call : $124.86 — upside +15%
Today : $155.08 — upside -7%
Expected +15% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on RVTY : 0% (1 call matured) · 📊 on Health : 48% · +0.6% (98 calls)
-28.3%
stock -28% · XLV -1%
matured Nov 5, 25
Frequently asked questions
Should I buy Revvity stock?
This isn't buy advice. For Revvity, the analyst consensus is "Buy", with an average price target of $126 (-19% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Revvity). We show the numbers — you decide.
Is it too late to buy Revvity? How high can it go?
The most bullish analyst target on Revvity is $165 (+6% above today's price); the average is $126. That's the upside they see. Check how reliable those analysts have actually been on Revvity on our site before trusting it.
Is Revvity still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Revvity, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Revvity? The case for and against
The arguments for and against, one by one, from the numbers: why invest in RVTY (and why hesitate).
What has Revvity's past performance been?
Historical returns and a "how much if I had invested" calculator: RVTY performance & returns.
Does Revvity pay a dividend?
Yield, consistency and growth history of the dividend: RVTY's dividend.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX